{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15268", "batch_size": 200, "batch_pos": 85, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment describes uncertainty factually, without high-potency verbs, metaphors, or other Q2 cues.", "method": "llm_batch", "batch_id": "batch_2_17556", "batch_size": 200, "batch_pos": 53, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "No moderate verb paired with significant scale/impact.", "method": "llm_batch", "batch_id": "batch_3_12716", "batch_size": 200, "batch_pos": 192, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14492", "batch_size": 200, "batch_pos": 188, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports factual statement, not a calming cue.", "method": "llm_batch", "batch_id": "batch_5_16060", "batch_size": 200, "batch_pos": 184, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser word in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_16796", "batch_size": 200, "batch_pos": 137, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment contains 'too early to tell' but this is not a bare negation about risk or impact.", "method": "llm_batch", "batch_id": "batch_7_19696", "batch_size": 200, "batch_pos": 125, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment describes uncertainty about a future capability ('how many doses Moderna will be able to manufacture'), which is a capability statement, without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_17808", "batch_size": 200, "batch_pos": 95, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
